Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 7/20 | 0.37 |
| ▸ | PPARA | Q07869 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3690487 | 1.00 | DPP4 (0.38) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL29726893 | 0.91 | DPP4 (0.40) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL28700468 | 0.91 | DPP4 (0.40) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL3678880 | 0.83 | RAB9A (0.47) | NPC1RAB9APPARGPPARAMEN1 | |
| SCHEMBL3678882 | 0.83 | RAB9A (0.47) | NPC1RAB9APPARGPPARAMEN1 | |
| SCHEMBL28484186 | 0.82 | NPC1 (0.40) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL16335401 | 0.82 | RAB9A (0.38) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL17779917 | 0.82 | RAB9A (0.38) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL2778024 | 0.82 | NPC1 (0.41) | DPP4NPC1RAB9APPARGPPARA | |
| SCHEMBL2744761 | 0.82 | NPC1 (0.41) | DPP4NPC1RAB9APPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9480250-B2 | Production of solid solutions of pesticides by short-term superheating and rapid drying | BASF SE (DE) | 2016-11-01 | — | — | US | disclosed |
| US-20100062940-A1 | Production of Solid Solutions of Pesticides by Short-Term Superheating and Rapid Drying | BASF SE (DE) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062940-A1 | Production of Solid Solutions of Pesticides by Short-Term Superheating and Rapid Drying | ACHE, CS, STOM | DPP4 99/4885NPC1 3441/4885RAB9A 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.